Posts in LSE:ANCR

Best AIM companies of 2017 confirmed

Best AIM companies of 2017 confirmed

Former AIM writer of the year Andrew Hore reveals the winners at this year's AIM Awards, and how many he guessed right.

Best AIM companies of 2017

Best AIM companies of 2017

The annual AIM Awards are almost upon us, so former AIM writer of the year Andrew Hore names the small-cap companies he thinks will take home the prizes.

2 stocks I reckon could help you achieve financial independence

Investor demand for Animalcare (LSE:ANCR) remained flat in Tuesday trading despite the release of impressive trading details.

The York-based business announced that revenues increased 7.9% in the 12 months to June 2017, to £15.9m, a result that pushed underlying EBITDA 13% higher to just under £4m.

Whilst Animalcare saw sales at its Animal Welfare Products arm rise 5.5% in the first half, to £2.9m, it was left to its Licensed Veterinary Medicines division to really steal the show.

Animalcare completes acquisition of Ecuphar

Animalcare has completed its acquisition of Ecuphar NV and a placing of 9,340,168 shares at 350p to raise approximately £32.7m, gross.

The placing consisted of 8,571,428 new shares by the company and the sale of 768,740 shares sold by the selling shareholders at the placing price.

At 8:09am: (LON:ANCR) Animalcare Group PLC share price was +2.5p at 357.5p

Animalcare shareholders approve acquisition and placing

Animalcare Group has confirmed that, at the General Meeting held today, all resolutions in connection with the the proposed share placing and the acquisition of Ecuphar NV were passed.

The acquisition and placing are expected to complete tomorrow.

In aggregate, 38,691,790 New Ordinary Shares have been allotted and issued pursuant to the Proposals, comprising 8,571,428 New Placing Shares, 1,368,896 Option Shares and 28,751,466 Consideration Shares.

At 1:22pm: (LON:ANCR) Animalcare Group PLC share price was +2.5p at 357.5p

Top ranked shares for the future

Top ranked shares for the future

After upgrading his decision engine, companies analyst Richard Beddard thinks he's got to the heart of investing and the reasons we so often make mistakes.

A high-flying small-cap worth buying?

A high-flying small-cap worth buying?

This AIM company has just completed a complicated deal, but don't worry, companies analyst Richard Beddard has managed to make sense of it all.

Animalcare resumes trading on AIM

Trading in Animalcare's shares has resumed on AIM following the publication of an admission document for the proposed acquisition of Ecuphar.

At 9:56am: (LON:ANCR) Animalcare Group PLC share price was -20p at 372.5p

Animalcare to acquire Ecuphar

Animalcare Group has agreed to acquire Ecuphar NV, a European animal health company focused on the development and sale of veterinary pharmaceutical products.

The acquisition constitutes a reverse takeover under AIM Rules and is conditional upon shareholder approval.

Animalcare said the consideration for the acquisition was structured on a consolidated Animalcare/Ecuphar enlarged issued share capital ratio of 37:63 (after taking into account dilution from certain Animalcare incentive arrangements).

It said this would be satisfied through the issue of consideration shares and cash to the Ecu

10 top AIM stocks for ISA season

10 top AIM stocks for ISA season

Despite thrashing blue-chips in the past year, there are still some great small-caps worth buying. Stockopedia's Ben Hobson names the very best quality and momentum stocks on AIM right now.